BACKGROUND: Hospitalization and lab confirmed cases of H1N1 have been reported during the first wave of the 2009 pandemic but these are not accurate measures of influenza incidence in the population. We estimated the cumulative incidence of pandemic (H1N1) influenza among pregnant women in the province of Manitoba during the first wave of the 2009 pandemic. METHODS: Two panels of stored frozen serum specimens collected for routine prenatal screening were randomly selected for testing before (March 2009, n = 252) and after (August 2009, n = 296) the first wave of the pandemic. A standard hemagglutination inhibition assay was used to detect the presence of IgG antibodies against the pandemic (H1N1) 2009 virus. The cumulative incidence of pandemic (H1N1) influenza was calculated as the difference between the point prevalence rates in the first and second panels. RESULTS: Of the specimens collected in March, 7.1% were positive for the IgG antibodies (serum antibody titre ≥ 1:40). The corresponding prevalence was 15.7% among the specimens collected in August. The difference indicated a cumulative incidence of 8.6% (95% confidence interval [CI] 3.2%-13.7%). The rate differed geographically, the highest being in the northern regions (20.8%, 95% CI 7.9%-31.8%), as compared with 4.0% (95% CI 0.0%-11.9%) in Winnipeg and 8.9% (95% CI 0.0%-18.8%) in the rest of the province. INTERPRETATION: We estimated that the cumulative incidence of pandemic (H1N1) influenza among pregnant women in Manitoba during the first wave of the 2009 pandemic was 8.6%. It was 20.8% in the northern regions of the province.
BACKGROUND: Hospitalization and lab confirmed cases of H1N1 have been reported during the first wave of the 2009 pandemic but these are not accurate measures of influenza incidence in the population. We estimated the cumulative incidence of pandemic (H1N1) influenza among pregnant women in the province of Manitoba during the first wave of the 2009 pandemic. METHODS: Two panels of stored frozen serum specimens collected for routine prenatal screening were randomly selected for testing before (March 2009, n = 252) and after (August 2009, n = 296) the first wave of the pandemic. A standard hemagglutination inhibition assay was used to detect the presence of IgG antibodies against the pandemic (H1N1) 2009 virus. The cumulative incidence of pandemic (H1N1) influenza was calculated as the difference between the point prevalence rates in the first and second panels. RESULTS: Of the specimens collected in March, 7.1% were positive for the IgG antibodies (serum antibody titre ≥ 1:40). The corresponding prevalence was 15.7% among the specimens collected in August. The difference indicated a cumulative incidence of 8.6% (95% confidence interval [CI] 3.2%-13.7%). The rate differed geographically, the highest being in the northern regions (20.8%, 95% CI 7.9%-31.8%), as compared with 4.0% (95% CI 0.0%-11.9%) in Winnipeg and 8.9% (95% CI 0.0%-18.8%) in the rest of the province. INTERPRETATION: We estimated that the cumulative incidence of pandemic (H1N1) influenza among pregnant women in Manitoba during the first wave of the 2009 pandemic was 8.6%. It was 20.8% in the northern regions of the province.
Authors: Titilayo Oluyomi-Obi; Lisa Avery; Carol Schneider; Anand Kumar; Stephen Lapinsky; Savas Menticoglou; Ryan Zarychanski Journal: J Obstet Gynaecol Can Date: 2010-05
Authors: Tini Garske; Judith Legrand; Christl A Donnelly; Helen Ward; Simon Cauchemez; Christophe Fraser; Neil M Ferguson; Azra C Ghani Journal: BMJ Date: 2009-07-14
Authors: Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon Journal: Lancet Date: 2010-01-21 Impact factor: 79.321
Authors: Matthew R Sandbulte; Gretchen S Jimenez; Adrianus C M Boon; Larry R Smith; John J Treanor; Richard J Webby Journal: PLoS Med Date: 2007-02 Impact factor: 11.069
Authors: Joel G Ray; Allison J McGeer; Jennifer M Blake; Gerald Lebovic; Graeme N Smith; Mark H Yudin Journal: CMAJ Date: 2014-02-04 Impact factor: 8.262
Authors: B Sertogullarindan; B Ozbay; H Gunini; A Sunnetcioglu; A Arisoy; H M Bilgin; B Mermit Cilingir; M Duran; H Yildiz; S Ekin; Ai Baran Journal: Afr Health Sci Date: 2011-06 Impact factor: 0.927
Authors: Anna J X Zhang; Kelvin K W To; Herman Tse; Kwok-Hung Chan; Kun-Yuan Guo; Can Li; Ivan F N Hung; Jasper F W Chan; Honglin Chen; Sidney Tam; Kwok-Yung Yuen Journal: Clin Vaccine Immunol Date: 2011-09-07
Authors: Deshayne B Fell; David L Buckeridge; Robert W Platt; Jay S Kaufman; Olga Basso; Kumanan Wilson Journal: Am J Epidemiol Date: 2016-07-22 Impact factor: 4.897
Authors: Laura H Thompson; Salaheddin M Mahmud; Yoav Keynan; James F Blanchard; Joyce Slater; Magdy Dawood; Keith Fowke; Paul Van Caeseele; Marissa Becker Journal: Can J Infect Dis Med Microbiol Date: 2012 Impact factor: 2.471